0001579010
false
0001579010
2021-12-31
2021-12-31
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13
or15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): December 31, 2021
LIFE ON EARTH, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
000-55464 |
|
46-2552550 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(IRS Employer
Identification Number) |
1345 6th Ave.
2nd Floor
New York, NY
10105 |
|
(Address of principal
executive offices) (zip code)
(646) 844-9897
(Registrant’s telephone number, including
area code)
Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act: None
Title of each Class |
Trading Symbol |
Name of each exchange on which registered |
N/A |
N/A |
N/A |
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐
If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. X
05/31
Section 2 - Financial Information
Item 2.01 Completion of Acquisition or
Disposition of Assets.
On December 17, 2021, we entered into a Stock
Purchase Agreement (the “Agreement”) with CareClix Holdings, Inc., a Florida corporation (“SOLI”). On December
31, 2031, under the terms of a Management Operating Agreement, we agreed to a partial closing of the transaction set forth in the SPA
(the “Transaction”) with the final closing to occur on the effectiveness of a registration statement for the shares to be
issued as part of the consideration.
In the partial closing, we acquired 100% ownership
of the operating subsidiaries of SOLI, which include CareClix, Inc., a Virginia corporation, CareClix Services, Inc., a Florida corporation,
MyCareClix, Inc., a Florida corporation, and CareClix RPM, Inc., a Florida corporation (collectively, the “CareClix Group”).
In exchange for ownership of the CareClix Group, we will issue the following securities to the common shareholders of SOLI:
50,000,000 shares of our common
stock; and shares of a new class of preferred stock to be designated as Series E Preferred Stock. The shares of Series E Preferred stock
to be designated and issued to the shareholders of CareClix shall be up to approximately 2,100,000 Series E Preferred shares with a convertibility
ratio, under the current share structure, of 100 to 1 into our shares of common stock with conversion occurring automatically when our
Articles of Incorporation have been amended to authorize sufficient common shares for the conversion.
4,000,000 shares of our Series A
Preferred Stock, over a period of time, to Mr. Charles Scott, the Chairman and majority shareholder of SOLI, with 2,500,000 shares issued
at the December 31, 2021 partial closing, 600,000 shares to be issued 45 days after closing, and 900,000 shares to be issued 90 days after
closing. Shares of our Series A Preferred Stock, which are not convertible and do not receive dividends, are entitled to cast 50 votes
per share on all matters submitted to the vote or consent of our shareholders.
Upon the final closing of the Transaction,
the former shareholders of SOLI will hold approximately seventy percent of our issued and outstanding common equity on a fully diluted
basis and will hold the majority of our total shareholder voting power.
The final closing of the Transaction is subject
to the effectiveness of a registration statement on Form S-4 to be filed registering the issuance of our shares of common stock and shares
of Series E Preferred Stock to the common shareholders of CareClix. We are undertaking to file the S-4 registration statement, which will
be filed as soon as a pending audit of the financial statements of the acquired CareClix companies is completed.
Pending the final Closing, SOLI and LFER will complete
the operational changes under the Management Operating Agreement effective December 31, 2021, so that the CareClix Group and LFER can
begin acting as a unit pending the effective date of the S-4 registration statement and issuance by LFER of the remainder of the agreed
consideration. In the event that the final closing is not completed by May 31, 2022, unless extended by agreement, then the partial closing
will be rescinded and the CareClix Group will be returned to SOLI.
Following the final Closing, there will be no affiliation,
as shareholder, debtor, creditor or otherwise, between SOLI and LFER
As part of the partial closing of the transaction,
2,500,000 shares of Series A voting preferred stock of LFER were issued to the current majority shareholder of the Company as part of
the consideration.
Section 5 - Corporate Governance and
Management
Item 5.01 Changes in Control of Registrant
Upon the final closing of the Transaction,
the former shareholders of SOLI will hold approximately seventy percent of our issued and outstanding common equity on a fully diluted
basis and will hold the majority of our total shareholder voting power.
Item 5.02 Departure of Directors or Certain
Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
As part of the Transaction, our Board of
Directors increased the size of our Board from 4 to 7 members and the following were appointed as additional members of our Board:
Charles O. Scott
Mr. Scott was appointed Chief Executive
Officer and Chairman of SOLI on June 21, 2017 and was majority its shareholder. Mr Scott now also has majority voting control of LFER..
Mr. Scott founded Pay Yourself First, Inc. in 2011 and currently serves as the CEO and Chairman. Mr. Scott also serves as an Executive
Director of Kramer Stromberg Financial Holdings, a company he founded in 1985. Mr. Scott graduated from the University of Virginia in
1976.
S. John Korangy, MD, MPH, DABR
Board Certified Neuroradiologist. Pioneer
in telemedicine. Founder of the CareClix software platform. Has formulated standards and guidelines for the practice of telemedicine and
has authored papers on telemedicine and the implementation of virtual health on a global basis. Dr. Korangy speaks nationally about utilizing
and deploying virtual health across the practice of medicine. Previously, Dr. Korangy served as Chief Medical Officer for United Radiology
Services and served as Department Chairman as well. He has chaired and served on numerous committees in hospitals, medical groups, and
medical societies. Dr. Korangy completed his medical degree at the George Washington University where he also obtained a master’s
in public health. He completed his medical training at Georgetown University, as well as at the National Institutes of Health. He lives
with his family in Potomac, MD.
A third new member will be added to our Board of Directors
shortly, as soon as appropriate due diligence and consents are completed.
Item 5.03 Amendments to Articles of Incorporation
or Bylaws
On December 31, 2021, our board of directors
and a majority of the holders of our Series A Preferred Stock approved an amendment to the Certificate of Designation for Series A Preferred
Stock increasing the number of authorized shares of Series A Preferred Stock to a total of 5,200,000 shares. The purpose of the amendment
was to authorize sufficient shares of Series A Preferred Stock to allow for the issuances required under the SPA with SOLI.
Also on December 31, 2021, our board of
directors approved a Certificate of Designation designating 2,500,000 shares as Series E Preferred Stock. After an amendment to our Certificate
of Incorporation to increase our authorized common shares to no less than the total number of shares required to allow such conversion,
Series E Preferred Stock will convert automatically to common stock at a ratio of 100 shares of common stock for each share of Series
E Preferred Stock. Series E Preferred Stock is entitled to vote as-if-converted to common stock on all matters submitted to a vote or
consent of our shareholders. Series E Preferred Stock has no special dividend rights and ranks equally with our common stock with respect
to rights on liquidation, winding up and dissolution.
Section 8 -
Other Events
Item 8.01 Other Events.
On December 31, 2021, we completed a partial closing
of the Transaction set forth in the Stock Purchase Agreement (“SPA”), effective as of December 17, 2022. The initial partial
closing of the Transaction with LFER, authorized the transfer of the following subsidiaries of SOLI to LFER effective January 1, 2022:
1) CareClix
Services, Inc, a Florida corporation
2) CareClix,
Inc., a Virginia corporation
3) MyCareClix
Inc., a Florida corporation
4) CareClix
RPM, Inc., a Florida corporation
At the partial closing approved by the Board of Directors
and a majority of shareholders of SOLI, SOLI conveyed the four subsidiaries to LFER in consideration for 4,000,000 shares of Series A
voting preferred stock of LFER to be issued directly to Charles Scott, majority shareholder of the Company and completion of the remaining
conditions to closing in the SPA, and LFER has undertaken to issue directly to SOLI shareholders, (i) 50,000,000 common shares of LFER
to certain designated SOLI shareholders, on the basis of one LFER common share for 50,000,000 common shares of SOLI outstanding at Closing
and (ii) to other SOLI designated shareholders, one Series E non-voting convertible preferred share of LFER for each 100 common shares
of SOLI held by the remaining shareholders of SOLI outstanding at Closing, with convertibility of the Series E preferred shares to equal
100 shares of our common stock for each share of such preferred stock and with conversion occurring automatically when our Articles of
Incorporation have been amended to authorize sufficient common shares. We will register the common .and Series E convertible preferred
shares to be issued to the SOLI shareholders and the Closing will be completed when that registration statement is declared effective
by the SEC. When the final closing has been completed and the Series E preferred shares are converted into our common stock, the net effect
will be that each common shareholder of SOLI before the partial closing will have received one share of our common stock for each common
share of SOLI outstanding before the Transaction. Mr. Scott, as majority shareholder of SOLI before the partial Closing of the Transaction,
will by virtue of the Series A Preferred stock of LFER to be issued to him, be the voting majority shareholder of LFER.
Pending the final Closing, SOLI and LFER will complete
the operational changes under a Management Operating Agreement effective December 31, 2021, so that the CareClix subsidiaries and LFER
can begin acting as a unit pending the effective date of the S-4 registration statement and issuance by LFER of the balance of the agreed
consideration.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits.
9(a) Financial statements of businesses
or funds acquired. The financial statements of the four CareClix subsidiaries included in the Transaction have been restated to a fiscal
year ending May 31 from their calendar year reporting to conform to the fiscal year of LFER and are being audited for the fiscal years
ended May 31 2019, 2020 and 2021. These audited financial statements will be included in our Form S-4 to be filed to complete the transaction
and in a Current Report on Form 8-K to be filed following the complete closing of the transaction on the effectiveness of our Form S-4.
9(d) Exhibits.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: January 6, 2022 |
LIFE ON EARTH, INC. |
|
|
|
|
|
|
By: |
/s/ Mahmood Khan |
|
|
Name: |
Mahmood Khan |
|
|
Title: |
Chief Executive Officer |
|
|
|
|
|
|
|
|
|
Exhibit 3.1
Certificate of Amendment to Certificate of Designation for Series A Preferred Stock
Please refer to the accompanying Exhibit 3.1. It is saved in PDF format.
Exhibit 3.2
Certificate of Designation for Series E Preferred Stock
Please refer to the accompanying Exhibit 3.2. It is saved in PDF format.
Exhibit 10.1
Management Operating Agreement
Please refer to the accompanying Exhibit 10.1. It is saved in PDF format.
v3.21.4
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionEnd date of current fiscal year in the format --MM-DD.
+ References
+ Details
Name: |
dei_CurrentFiscalYearEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:gMonthDayItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
This regulatory filing also includes additional resources:
exhibit_3-1.pdf
exhibit_3-2.pdf
exhibit_10-1.pdf
Life on Earth (CE) (USOTC:LFER)
Historical Stock Chart
From Mar 2024 to Apr 2024
Life on Earth (CE) (USOTC:LFER)
Historical Stock Chart
From Apr 2023 to Apr 2024